Lps

CPP Investments will mull secondaries sales to ‘trim older exposure’

The pension giant aims to deploy about C$20bn into private equity this year, global head of PE Caitlin Gubbels tells PEI.

Younger, high-quality portfolios gain ground in LP-led market – NEXUS

‘Today’s market for secondaries has evolved to a market of asset selection and cherry picking,’ Ardian’s Wilfred Small told attendees at PEI’s conference.

How an LP and a GP are approaching the slower exit environment

In the first episode of PEI Group’s new podcast series Commitment Issues, Yangge Seaman of Children’s Health and Steven Batchelor of Hg discuss how both sides are seeking greater liquidity from their portfolios

GIC emerges as lead buyer on Meridiam’s €2bn+ CV

The structure will consist of a portfolio of 22 infrastructure assets that are held by the firm’s legacy funds.

Secondaries’ next iteration: market capitalisation in 2026 and beyond

In this edition of Secondaries Investor’s Second Thoughts podcast, Evercore’s global head of private capital advisory Nigel Dawn discusses the outlook for activity in 2026 and the key trends shaping the capitalisation of the market over the longer term.

Florida SBA explores multibillion-dollar portfolio sale

The pension has been actively pursuing opportunities in the secondaries market over the past few years.

LPs expanding into more diverse infra secondaries strategies

Narrow discounts mean infrastructure remains a first port of call for secondaries sellers.

MassPRIM to expand secondaries capabilities in 2026

The $123bn pension system’s latest ambitions follow the creation of a GP-led-focused investment role in 2024.

Report: UK pensions could sell up to £8bn on secondaries market in the next year

More than 60% of defined benefit pension scheme advisers and trustees expect these pensions to utilise the secondaries market to sell illiquid assets, according to a report from MeltX and Mallowstreet.

More than a quarter of single-family offices plan to increase secondaries exposure – JPMorgan

Around two-thirds of the over 300 family offices surveyed by JPMorgan have no exposure to secondaries.